Eversept Partners, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001697013

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 68 positions · Total reported value $1.18B · Top-10 concentration 62.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.4% · 29 new · 41 cut · 27 exited

Active Share (vs S&P 500): 97.5% · vs QQQ: 99.8% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +11.9% · vs SPY -2.9% · Prev Value $1.87B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2023 13F filing, Eversept Partners, LP disclosed 68 equity positions with a combined reported value of $1.18B. The filing implies a focused portfolio: its ten largest positions account for 62.5% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were QQQ ($143.31M), GSK ($118.15M), NTRA ($110.30M). By sector, the heaviest allocations are Health Care 65.0%, Industrials 3.6%.

Versus the prior quarter, Eversept Partners, LP opened 29 new positions, trimmed 41 and fully exited 27, a turnover rate of 66.4% of positions.

The largest new positions opened in Q3 2023 were QQQ ($143.31M), GSK ($118.15M), NTRA ($110.30M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • QQQ INVESCO QQQ TR · $143.31M
  • GSK GSK PLC ADR F · $118.15M
  • NTRA NATERA INC · $110.30M
  • SPY STATE STR SPDR S&P 500 ETF T · $102.60M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · $70.91M
  • UTHR UNITED THERAPEUTICS CORP DEL · $60.51M
  • INSP INSPIRE MED SYS INC COM · $38.30M
  • SNDX SYNDAX PHARMACEUTICALS INC · $37.70M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Eversept Partners, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Eversept Partners, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 119 US equity positions with a combined value of $1.91B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-108771 (status: Approved), registered 2017-01-11
  • Regulatory AUM (Form ADV): $2.65B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 99%, registered investment companies 1%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: eversept.com

Portfolio Structure

  • 119 positions · $1.91B reported value (Q2 2026)
  • Top 10 holdings = 46.1% of reported value
  • Largest position: UTHR (UNITED THERAPEUTICS CORP DEL) at 8.2%
  • Average position size: $16.06M

Sector Tilt

  • Health Care 88.2%
  • Real Estate 5.6%
  • Industrials 1.3%
  • (classified holdings cover 96% of value)

Quarterly Activity

  • Q2 2026: 29 new, 42 added, 41 reduced, 27 exited
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 65.0%
Other 29.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 400.00K $143.31M 12.19%
12.19%
New
2 3.26M $118.15M 10.05%
10.05%
New
3 2.49M $110.30M 9.38%
9.38%
New
4 240.00K $102.60M 8.72%
8.72%
New
5 6.95M $70.91M 6.03%
6.03%
New
6 267.90K $60.51M 5.15%
5.15%
New
7 193.02K $38.30M 3.26%
3.26%
New
8 2.60M $37.70M 3.21%
3.21%
New
9 110.07K $27.08M 2.30%
2.30%
New
10 385.89K $26.27M 2.23%
2.23%
New
11 103.78K $25.75M 2.19%
2.19%
New
12 338.52K $24.73M 2.10%
2.10%
New
13 205.81K $23.81M 2.02%
2.02%
New
14 166.78K $22.90M 1.95%
1.95%
New
15 7.15M $20.72M 1.76%
1.76%
New
16 1.48M $20.27M 1.72%
1.72%
New
17 2.48M $17.55M 1.49%
1.49%
New
18 84.46K $16.82M 1.43%
1.43%
New
19 588.14K $16.19M 1.38%
1.38%
New
20 190.61K $13.13M 1.12%
1.12%
New
21 108.77K $12.62M 1.07%
1.07%
New
22 252.45K $11.45M 0.97%
0.97%
New
23 2.64M $11.16M 0.95%
0.95%
New
24 190.43K $9.71M 0.83%
0.83%
New
25 255.32K $9.63M 0.82%
0.82%
New
26 21.69K $9.45M 0.80%
0.80%
New
27 1.40M $8.85M 0.75%
0.75%
New
28 18.12K $8.82M 0.75%
0.75%
New
29 70.30K $8.60M 0.73%
0.73%
New
30 93.70K $8.31M 0.71%
0.71%
New
31 8.43M $7.76M 0.66%
0.66%
New
32 443.27K $6.80M 0.58%
0.58%
New
33 90.00K $6.63M 0.56%
0.56%
New
34 23.12K $6.34M 0.54%
0.54%
New
35 660.62K $6.11M 0.52%
0.52%
New
36 1.45M $5.70M 0.48%
0.48%
New
37 2.35M $5.60M 0.48%
0.48%
New
38 1.71M $5.39M 0.46%
0.46%
New
39 1.74M $5.18M 0.44%
0.44%
New
40 21.00K $5.17M 0.44%
0.44%
New
41 286.75K $4.78M 0.41%
0.41%
New
42 41.83K $4.68M 0.40%
0.40%
New
43 122.64K $4.67M 0.40%
0.40%
New
44 23.04K $4.53M 0.39%
0.39%
New
45 452.32K $4.52M 0.39%
0.39%
New
46 1.68M $4.42M 0.38%
0.38%
New
47 50.00K $4.26M 0.36%
0.36%
New
48 365.90K $4.07M 0.35%
0.35%
New
49 12.23K $4.01M 0.34%
0.34%
New
50 4.43M $3.69M 0.31%
0.31%
New

FAQ

What did Eversept Partners, LP buy in 2023-Q3?

In its 2023-Q3 13F filing, Eversept Partners, LP reported 68 equity positions worth $1.18B in aggregate; its largest disclosed positions were QQQ ($143.31M), GSK ($118.15M), NTRA ($110.30M).

How large is Eversept Partners, LP's portfolio?

Eversept Partners, LP reported $1.18B of long equity holdings across 68 positions as of 2023-Q3. Top-10 holdings account for 62.5% of reported value.

What is Eversept Partners, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/eversept-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →